OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F5946 for the procurement of OMEPRAZOLE EXTENDED, identified by NSN 6505013142716, as a delivery order under the base contract SPE2DX25D9900. The award was issued on May 21, 2026, and the total contract price is detailed in the official award documentation. The acquisition is classified as a federal transaction with no specific set-aside designation, and the performance location is within the United States, though no specific city or state is provided. The solicitation was posted on July 23, 2026, and the primary point of contact information is not listed in the public record. All contractual obligations and delivery requirements are tied to the DLA’s supply chain for pharmaceuticals supporting defense and federal operations.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
